Virpax Pharmaceuticals, Inc.
VRPX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $40 | $94 | $182 | $1,005 |
| - Cash | $2 | $9 | $19 | $37 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $39 | $85 | $163 | $968 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$12,080 | -$15 | $0 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$12,067 | -$15 | -$21 | -$12 |
| % Margin | – | – | – | – |
| EPS Diluted | -2,836.41 | -12.97 | -18.32 | -10.37 |
| % Growth | -21,769% | 29.2% | -76.7% | – |
| Operating Cash Flow | -$16,713 | -$10 | -$18 | -$15 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$16,713 | -$10 | -$18 | -$15 |